Insiders who reported open-market trades in the last 12 months at the companies Leonard E. Post files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Brian Guan-Chyun Liu - $24.81M in CGON purchases and sales in the last 12 months
James Mulay - $3.78M in CGON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Leonard E. Post is a corporate insider, tracked as Director of CG Oncology, Inc. (CGON). InsiderAlpha holds 22 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Leonard E. Post submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Leonard E. Post been buying or selling stock?
Recorded transactions: 0 open-market purchases and 21 open-market sales ($1.62M) across all tracked filings.
Leonard E. Post is Director of CG Oncology, Inc. (CGON). 22 SEC Form 4 filings on record going back to 2024, most recently on 19 October 2026. Most recent open-market trade: sold $31K of CGON on 19 October 2026. Lifetime open-market sales: $1.62M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Leonard E. Post.
InsiderAlpha's records for Leonard E. Post go back to 2024: 22 primary Form 4 filings, an average of 7.3 per year. 36 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
